ClinicalTrials.gov
ClinicalTrials.gov Menu

A Preference Study Comparing Kristalose® and Liquid Lactulose

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00712543
Recruitment Status : Completed
First Posted : July 10, 2008
Results First Posted : September 27, 2011
Last Update Posted : September 27, 2011
Sponsor:
Information provided by (Responsible Party):
Cumberland Pharmaceuticals

Brief Summary:
This study will evaluate whether patients have an overall preference for Kristalose® or liquid lactulose based on taste, consistency, and portability.

Condition or disease Intervention/treatment Phase
Constipation Drug: lactulose (Kristalose®) Drug: liquid lactulose Phase 4

Detailed Description:
This study will evaluate whether patients have an overall preference for Kristalose® or liquid lactulose based on taste, consistency, and portability.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 50 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Preference Study Comparing Kristalose® and Liquid Lactulose in the Treatment of Constipation
Study Start Date : June 2009
Actual Primary Completion Date : September 2009
Actual Study Completion Date : September 2009

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Constipation
Drug Information available for: Lactulose

Arm Intervention/treatment
Experimental: 1
Kristalose®, as prescribed, for 7 days.
Drug: lactulose (Kristalose®)
Crystals to be dissolved in water and taken as prescribed.
Other Name: Kristalose®

Experimental: 2
Liquid lactulose, as prescribed, for 7 days.
Drug: liquid lactulose
Liquid to be taken as prescribed.




Primary Outcome Measures :
  1. Patient Preference in Terms of Overall Preference and Preference of Taste, Consistency, and Portability. [ Time Frame: 14 days ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients with recently diagnosed chronic constipation requiring treatment.

Exclusion Criteria:

  • Patients with galactosemia (galactose-sensitive diet).
  • Patients less than 18 years of age.
  • Patients currently on lactulose therapy.
  • Inability to understand the requirements of the study or be unwilling to provide written informed consent (as evidenced by signature on an informed consent document approved by an Institutional Review Board [IRB]) and agree to abide by the study restrictions.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00712543


Locations
United States, New York
Arya Gastroenterology Associates
Brooklyn, New York, United States, 11237
United States, North Carolina
Wake Research Associates
Raleigh, North Carolina, United States, 27612
United States, Ohio
Rapid Medical Research
Cleveland, Ohio, United States, 44122
Sponsors and Collaborators
Cumberland Pharmaceuticals

Responsible Party: Cumberland Pharmaceuticals
ClinicalTrials.gov Identifier: NCT00712543     History of Changes
Other Study ID Numbers: KR-001
First Posted: July 10, 2008    Key Record Dates
Results First Posted: September 27, 2011
Last Update Posted: September 27, 2011
Last Verified: August 2011

Keywords provided by Cumberland Pharmaceuticals:
constipation
laxative
lactulose
Kristalose®

Additional relevant MeSH terms:
Constipation
Signs and Symptoms, Digestive
Signs and Symptoms
Lactulose
Gastrointestinal Agents